These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1903170)

  • 21. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA; Nafe R; Schlote W
    Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 14-3-3 proteins and zeta isoform containing neurofibrillary tangles in patients with Alzheimer's disease.
    Umahara T; Uchihara T; Tsuchiya K; Nakamura A; Iwamoto T; Ikeda K; Takasaki M
    Acta Neuropathol; 2004 Oct; 108(4):279-86. PubMed ID: 15235803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tau in situ hybridization in normal and Alzheimer brain: localization in the somatodendritic compartment.
    Kosik KS; Crandall JE; Mufson EJ; Neve RL
    Ann Neurol; 1989 Sep; 26(3):352-61. PubMed ID: 2508535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunocytochemistry of neurofibrillary tangles with antibodies to subregions of tau protein: identification of hidden and cleaved tau epitopes and a new phosphorylation site.
    Dickson DW; Ksiezak-Reding H; Liu WK; Davies P; Crowe A; Yen SH
    Acta Neuropathol; 1992; 84(6):596-605. PubMed ID: 1281953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease.
    Mukaetova-Ladinska EB; Harrington CR; Roth M; Wischik CM
    Am J Pathol; 1993 Aug; 143(2):565-78. PubMed ID: 8342603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Localization of HtrA2/Omi immunoreactivity in brains affected by Alzheimer's disease.
    Kawamoto Y; Ito H; Kobayashi Y; Suzuki Y; Takahashi R
    Neuroreport; 2010 Dec; 21(17):1121-5. PubMed ID: 20938363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequestration of tau by granulovacuolar degeneration in Alzheimer's disease.
    Bondareff W; Wischik CM; Novak M; Roth M
    Am J Pathol; 1991 Sep; 139(3):641-7. PubMed ID: 1909492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thiazin red as a neuropathological tool for the rapid diagnosis of Alzheimer's disease in tissue imprints.
    Luna-Muñoz J; Peralta-Ramirez J; Chávez-Macías L; Harrington CR; Wischik CM; Mena R
    Acta Neuropathol; 2008 Nov; 116(5):507-15. PubMed ID: 18810470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcineurin immunoreactivity in Alzheimer's disease.
    Billingsley ML; Ellis C; Kincaid RL; Martin J; Schmidt ML; Lee VM; Trojanowski JQ
    Exp Neurol; 1994 Apr; 126(2):178-84. PubMed ID: 7925818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tau-2 immunoreactivity of corpora amylacea in the human retina and optic nerve.
    Loeffler KU; Edward DP; Tso MO
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2600-3. PubMed ID: 7686896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of ubiquitin immunoreactivities at both ends of neuropil threads. Possible bidirectional growth of neuropil threads.
    Iwatsubo T; Hasegawa M; Esaki Y; Ihara Y
    Am J Pathol; 1992 Feb; 140(2):277-82. PubMed ID: 1310831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease. Demonstration with a panel of antibodies against Tau proteins.
    Delacourte A; Flament S; Dibe EM; Hublau P; Sablonnière B; Hémon B; Shérrer V; Défossez A
    Acta Neuropathol; 1990; 80(2):111-7. PubMed ID: 2117840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal tau species are produced during Alzheimer's disease neurodegenerating process.
    Flament S; Delacourte A
    FEBS Lett; 1989 Apr; 247(2):213-6. PubMed ID: 2497028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of tau proteins in the normal human central and peripheral nervous system.
    Trojanowski JQ; Schuck T; Schmidt ML; Lee VM
    J Histochem Cytochem; 1989 Feb; 37(2):209-15. PubMed ID: 2492045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Massive somatodendritic sprouting of cortical neurons in Alzheimer's disease.
    Ihara Y
    Brain Res; 1988 Aug; 459(1):138-44. PubMed ID: 3139259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ubiquitin and microtubule-associated protein tau immunoreactivity each define distinct structures with differing distributions and solubility properties in Alzheimer brain.
    Shaw G; Chau V
    Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2854-8. PubMed ID: 2833758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunochemical and biochemical characterization of tau proteins in normal and Alzheimer's disease brains with Alz 50 and Tau-1.
    Ksiezak-Reding H; Binder LI; Yen SH
    J Biol Chem; 1988 Jun; 263(17):7948-53. PubMed ID: 3131334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-ganglioside GD1a monoclonal antibody recognizes senile plaques in the brains of patients with Alzheimer-type dementia.
    Nishinaka T; Iwata D; Shimada S; Kosaka K; Suzuki Y
    Neurosci Res; 1993 Jul; 17(2):171-6. PubMed ID: 7694209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amyloid scrapie plaques in mice, and Alzheimer senile plaques, share common antigens with tau, a microtubule-associated protein.
    Brion JP; Fraser H; Flament-Durand J; Dickinson AG
    Neurosci Lett; 1987 Jul; 78(1):113-8. PubMed ID: 3112659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of apolipoprotein E in normal and diverse neurodegenerative disease brain.
    Bao F; Arai H; Matsushita S; Higuchi S; Sasaki H
    Neuroreport; 1996 Jul; 7(11):1733-9. PubMed ID: 8905654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.